Enovis (ENOV) Cash from Financing Activities (2010 - 2026)

Enovis (ENOV) reported Cash from Financing Activities of $26.0 million for Q2 2026, down 49.16% year-over-year from $51.2 million in Q2 2025, and up 135.69% quarter-over-quarter from -$72.9 million in Q4 2025.

Enovis (ENOV) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Enovis (ENOV) has 17 years of Cash from Financing Activities data on file, last reported at $26.0 million in Q2 2026.

  • Cash from Financing Activities for Q2 2026 came in at $26.0 million, down 49.16% year-over-year; the trailing twelve-month figure through Apr 2026 was -$77.6 million (down 331.74% YoY), and the FY2025 annual result was -$52.4 million, down 106.19% from the prior year.
  • Cash from Financing Activities grew to $26.0 million in Q2 2026 per ENOV's latest filing, from -$72.9 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $864.5 million in Q1 2024 and troughed at -$495.5 million in Q3 2022.
  • A 5-year average of $28.4 million and a median of $2.5 million in 2024 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities surged 3429.02% in 2024, then slumped 24837.16% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $41.6 million in 2022, then plunged by 93.3% to $2.8 million in 2023, then plunged by 819.97% to -$20.1 million in 2024, then slumped by 263.12% to -$72.9 million in 2025, then surged by 135.69% to $26.0 million in 2026.
  • Business Quant data shows ENOV's Cash from Financing Activities at $26.0 million in Q2 2026, -$72.9 million in Q4 2025, and -$36.9 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 17.31 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.51 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 21.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -97.90 Mn
10 Enovis 1.26 Bn 1.23 Bn 365.49 Mn 26.02 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 26.02 Mn
Apr 3, 2026 26.02 Mn
Dec 31, 2025 -72.92 Mn
Dec 31, 2025 -72.92 Mn
Oct 3, 2025 -36.91 Mn
Oct 3, 2025 -36.91 Mn
Jul 4, 2025 6.23 Mn
Jul 4, 2025 6.23 Mn
Apr 4, 2025 51.19 Mn
Apr 4, 2025 51.19 Mn
Dec 31, 2024 -20.08 Mn
Dec 31, 2024 -20.08 Mn
Sep 27, 2024 -148,000.00
Sep 27, 2024 -148,000.00
Jun 28, 2024 2.51 Mn
Jun 28, 2024 2.51 Mn
Mar 29, 2024 864.54 Mn
Mar 29, 2024 864.54 Mn
Dec 31, 2023 2.79 Mn
Dec 31, 2023 2.79 Mn